Molecular-genetic methods of laryngeal cancer prognosis

Laryngeal and laryngopharyngeal cancers are the most common malignancies among head and neck tumors. Currently, there are no distinctive molecular-genetic assessment criteria and markers for early detection and prognosis of laryngeal cancer. It is obvious that there is necessity in novel approaches directed to the search for molecular-biological and viral-genetic markers for forming groups at high risk for cancer development and screening patients with precancerous diseases as well as for predicting both the risk of cancer development and disease outcome.